SEC Form 4 · accession 0001209191-16-121833
Viridian Therapeutics, Inc.\DE · VRDN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tamara A Seymour
Officer — CFO, Secretary, Treasurer
Period of report
Mar 28, 2016
Accepted (ET)
May 19, 2016 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590750
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | $0.00 | Mar 28, 2016 | A | 100,000 | A | — | Mar 28, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive the economic equivalent of one share of the Issuer's common stock, payable in shares of common stock, cash or some combination of both, as determined by the Issuer.
- F2The Restricted Stock Unit vests 25% on March 28, 2017 and 6.25% of the remaining number of shares vests quarterly thereafter on each of the following 12 quarters, subject to the Reporting Person's continuous service to the Issuer on each such date.